<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0002-4794-31
</NDCCode>
<PackageDescription>
1 BOTTLE in 1 CARTON (0002-4794-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4794-01)
</PackageDescription>
<NDC11Code>
00002-4794-31
</NDC11Code>
<ProductNDC>
0002-4794
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Foundayo
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Orforglipron
</NonProprietaryName>
<DosageFormName>
TABLET, FILM COATED
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20260401
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA220934
</ApplicationNumber>
<LabelerName>
Eli Lilly and Company
</LabelerName>
<SubstanceName>
ORFORGLIPRON CALCIUM
</SubstanceName>
<StrengthNumber>
5.5
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-04-04
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260401
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>